Selected research
Industry Research
Second Generation Sulfonylureas Industry Research Report 2026
Market perspective
The global Second Generation Sulfonylureas market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Second Generation Sulfonylureas is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Second Generation Sulfonylureas is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Second Generation Sulfonylureas is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Second Generation Sulfonylureas include United Laboratories, Yiling Pharmaceutical, Takeda, Sanofi, Novo Nordisk, Merck, Eli Lilly, Jiangsu Hengrui Pharmaceuticals and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Second Generation Sulfonylureas market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Second Generation Sulfonylureas Market by Company
United Laboratories
Yiling Pharmaceutical
Takeda
Sanofi
Novo Nordisk
Merck
Eli Lilly
Jiangsu Hengrui Pharmaceuticals
Pfizer
Beijing Double-Crane Pharmaceutical
Huadong Medicine
Beijing Beilu Pharmaceutical
AstraZeneca
Boehringer Ingelheim
Second Generation Sulfonylureas Segment by Type
Glyburide
Glipizide
Gliclazide
Others
Second Generation Sulfonylureas Segment by Application
Clinic
Hospital
Pharmacy
Others
Second Generation Sulfonylureas Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Second Generation Sulfonylureas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Second Generation Sulfonylureas and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Second Generation Sulfonylureas.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Second Generation Sulfonylureas manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Second Generation Sulfonylureas by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Second Generation Sulfonylureas in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glyburide
- Glipizide
- Gliclazide
- Others
Applications
- Clinic
- Hospital
- Pharmacy
- Others
Companies covered
- United Laboratories
- Yiling Pharmaceutical
- Takeda
- Sanofi
- Novo Nordisk
- Merck
- Eli Lilly
- Jiangsu Hengrui Pharmaceuticals
- Pfizer
- Beijing Double-Crane Pharmaceutical
- Huadong Medicine
- Beijing Beilu Pharmaceutical
- AstraZeneca
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Second Generation Sulfonylureas Market Size (2021-2032)
- 2.2.2 Global Second Generation Sulfonylureas Sales (2021-2032)
- 2.2.3 Global Second Generation Sulfonylureas Market Average Price (2021-2032)
- 2.3 Second Generation Sulfonylureas by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glyburide
- 2.3.3 Glipizide
- 2.3.4 Gliclazide
- 2.3.5 Others
- 2.4 Second Generation Sulfonylureas by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Pharmacy
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Second Generation Sulfonylureas Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Second Generation Sulfonylureas Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Second Generation Sulfonylureas Revenue of Manufacturers (2021-2026)
- 3.4 Global Second Generation Sulfonylureas Average Price by Manufacturers (2021-2026)
- 3.5 Global Second Generation Sulfonylureas Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Second Generation Sulfonylureas, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Second Generation Sulfonylureas, Product Type & Application
- 3.8 Global Manufacturers of Second Generation Sulfonylureas, Established Date
- 3.9 Global Second Generation Sulfonylureas Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 United Laboratories
- 4.1.1 United Laboratories Company Information
- 4.1.2 United Laboratories Business Overview
- 4.1.3 United Laboratories Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 United Laboratories Second Generation Sulfonylureas Product Portfolio
- 4.1.5 United Laboratories Recent Developments
- 4.2 Yiling Pharmaceutical
- 4.2.1 Yiling Pharmaceutical Company Information
- 4.2.2 Yiling Pharmaceutical Business Overview
- 4.2.3 Yiling Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yiling Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 4.2.5 Yiling Pharmaceutical Recent Developments
- 4.3 Takeda
- 4.3.1 Takeda Company Information
- 4.3.2 Takeda Business Overview
- 4.3.3 Takeda Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Takeda Second Generation Sulfonylureas Product Portfolio
- 4.3.5 Takeda Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Second Generation Sulfonylureas Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 Novo Nordisk
- 4.5.1 Novo Nordisk Company Information
- 4.5.2 Novo Nordisk Business Overview
- 4.5.3 Novo Nordisk Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Novo Nordisk Second Generation Sulfonylureas Product Portfolio
- 4.5.5 Novo Nordisk Recent Developments
- 4.6 Merck
- 4.6.1 Merck Company Information
- 4.6.2 Merck Business Overview
- 4.6.3 Merck Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merck Second Generation Sulfonylureas Product Portfolio
- 4.6.5 Merck Recent Developments
- 4.7 Eli Lilly
- 4.7.1 Eli Lilly Company Information
- 4.7.2 Eli Lilly Business Overview
- 4.7.3 Eli Lilly Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Eli Lilly Second Generation Sulfonylureas Product Portfolio
- 4.7.5 Eli Lilly Recent Developments
- 4.8 Jiangsu Hengrui Pharmaceuticals
- 4.8.1 Jiangsu Hengrui Pharmaceuticals Company Information
- 4.8.2 Jiangsu Hengrui Pharmaceuticals Business Overview
- 4.8.3 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiangsu Hengrui Pharmaceuticals Second Generation Sulfonylureas Product Portfolio
- 4.8.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Second Generation Sulfonylureas Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Beijing Double-Crane Pharmaceutical
- 4.10.1 Beijing Double-Crane Pharmaceutical Company Information
- 4.10.2 Beijing Double-Crane Pharmaceutical Business Overview
- 4.10.3 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beijing Double-Crane Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 4.10.5 Beijing Double-Crane Pharmaceutical Recent Developments
- 4.11 Huadong Medicine
- 4.11.1 Huadong Medicine Company Information
- 4.11.2 Huadong Medicine Business Overview
- 4.11.3 Huadong Medicine Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Huadong Medicine Second Generation Sulfonylureas Product Portfolio
- 4.11.5 Huadong Medicine Recent Developments
- 4.12 Beijing Beilu Pharmaceutical
- 4.12.1 Beijing Beilu Pharmaceutical Company Information
- 4.12.2 Beijing Beilu Pharmaceutical Business Overview
- 4.12.3 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beijing Beilu Pharmaceutical Second Generation Sulfonylureas Product Portfolio
- 4.12.5 Beijing Beilu Pharmaceutical Recent Developments
- 4.13 AstraZeneca
- 4.13.1 AstraZeneca Company Information
- 4.13.2 AstraZeneca Business Overview
- 4.13.3 AstraZeneca Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AstraZeneca Second Generation Sulfonylureas Product Portfolio
- 4.13.5 AstraZeneca Recent Developments
- 4.14 Boehringer Ingelheim
- 4.14.1 Boehringer Ingelheim Company Information
- 4.14.2 Boehringer Ingelheim Business Overview
- 4.14.3 Boehringer Ingelheim Second Generation Sulfonylureas Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Boehringer Ingelheim Second Generation Sulfonylureas Product Portfolio
- 4.14.5 Boehringer Ingelheim Recent Developments
5 Global Second Generation Sulfonylureas Market Scenario by Region
- 5.1 Global Second Generation Sulfonylureas Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Second Generation Sulfonylureas Sales by Region: 2021-2032
- 5.2.1 Global Second Generation Sulfonylureas Sales by Region: 2021-2026
- 5.2.2 Global Second Generation Sulfonylureas Sales by Region: 2027-2032
- 5.3 Global Second Generation Sulfonylureas Revenue by Region: 2021-2032
- 5.3.1 Global Second Generation Sulfonylureas Revenue by Region: 2021-2026
- 5.3.2 Global Second Generation Sulfonylureas Revenue by Region: 2027-2032
- 5.4 North America Second Generation Sulfonylureas Market Facts & Figures by Country
- 5.4.1 North America Second Generation Sulfonylureas Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Second Generation Sulfonylureas Sales by Country (2021-2032)
- 5.4.3 North America Second Generation Sulfonylureas Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Second Generation Sulfonylureas Market Facts & Figures by Country
- 5.5.1 Europe Second Generation Sulfonylureas Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Second Generation Sulfonylureas Sales by Country (2021-2032)
- 5.5.3 Europe Second Generation Sulfonylureas Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Second Generation Sulfonylureas Market Facts & Figures by Country
- 5.6.1 Asia Pacific Second Generation Sulfonylureas Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Second Generation Sulfonylureas Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Second Generation Sulfonylureas Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Second Generation Sulfonylureas Market Facts & Figures by Country
- 5.7.1 South America Second Generation Sulfonylureas Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Second Generation Sulfonylureas Sales by Country (2021-2032)
- 5.7.3 South America Second Generation Sulfonylureas Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Second Generation Sulfonylureas Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Second Generation Sulfonylureas Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Second Generation Sulfonylureas Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Second Generation Sulfonylureas Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Second Generation Sulfonylureas Sales by Type (2021-2032)
- 6.1.1 Global Second Generation Sulfonylureas Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Second Generation Sulfonylureas Sales Market Share by Type (2021-2032)
- 6.2 Global Second Generation Sulfonylureas Revenue by Type (2021-2032)
- 6.2.1 Global Second Generation Sulfonylureas Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Second Generation Sulfonylureas Revenue Market Share by Type (2021-2032)
- 6.3 Global Second Generation Sulfonylureas Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Second Generation Sulfonylureas Sales by Application (2021-2032)
- 7.1.1 Global Second Generation Sulfonylureas Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Second Generation Sulfonylureas Sales Market Share by Application (2021-2032)
- 7.2 Global Second Generation Sulfonylureas Revenue by Application (2021-2032)
- 7.2.1 Global Second Generation Sulfonylureas Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Second Generation Sulfonylureas Revenue Market Share by Application (2021-2032)
- 7.3 Global Second Generation Sulfonylureas Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Second Generation Sulfonylureas Value Chain Analysis
- 8.1.1 Second Generation Sulfonylureas Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Second Generation Sulfonylureas Production Mode & Process
- 8.2 Second Generation Sulfonylureas Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Second Generation Sulfonylureas Distributors
- 8.2.3 Second Generation Sulfonylureas Customers
9 Global Second Generation Sulfonylureas Analyzing Market Dynamics
- 9.1 Second Generation Sulfonylureas Industry Trends
- 9.2 Second Generation Sulfonylureas Industry Drivers
- 9.3 Second Generation Sulfonylureas Industry Opportunities and Challenges
- 9.4 Second Generation Sulfonylureas Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst